Suchergebnisse - "Gentile, Davide"

PubPharm (34)

1

Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2

enthalten in: Viruses | 2024

von Gentile, D. | Chiummiento, L. | Santarsiere, A. | +7

2

Pyrrole Compounds from the Two-Step One-Pot Conversion of 2,5-Dimethylfuran for Elastomer Composites with Low Dissipation of Energy

enthalten in: Molecules (Basel, Switzerland) | 2024

von Naddeo, S. | Gentile, D. | Margani, F. | +4

3

An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2

enthalten in: Biomolecules | 2023

von Pennisi, R. | Gentile, D. | Rescifina, A. | +4

4

Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process

enthalten in: International journal of molecular sciences | 2022

von Gentile, D. | Coco, A. | Patamia, V. | +3

5

Correction to "Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin : A Shift in Activity from Antimicrobial to Anticancer Agents"

enthalten in: Journal of medicinal chemistry | 2022

von Fallica, A. | Barbaraci, C. | Amata, E. | +13

ErratumFor: J Med Chem. 2021 Aug 12;64(15):11597-11613. - PMID 34319100

6

In vivo wound healing effect of Italian and Algerian Pistacia vera L. resins

enthalten in: Fitoterapia | 2022

von Boudjelal, A. | Napoli, E. | Benkhaled, A. | +4

7

Artificial Intelligence Technologies for COVID-19 De Novo Drug Design

enthalten in: Preprints.org | 2022

von Floresta, G. | Zagni, C. | Gentile, D. | +2

8

Artificial Intelligence Technologies for COVID-19 De Novo Drug Design

enthalten in: International journal of molecular sciences | 2022

von Floresta, G. | Zagni, C. | Gentile, D. | +2

9

Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties

enthalten in: ACS chemical neuroscience | 2022

von Szczepańska, K. | Podlewska, S. | Dichiara, M. | +16

10

Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin : A Shift in Activity from Antimicrobial to Anticancer Agents

enthalten in: Journal of medicinal chemistry | 2021

von Fallica, A. | Barbaraci, C. | Amata, E. | +13

ErratumIn: J Med Chem. 2022 Aug 25;65(16):11414. - PMID 35947791